In this issue of Blood, Rumi et al and Rotunno et al demonstrate that essential thrombocythemia (ET) patients with calreticulin mutations exhibit lower leukocyte and hemoglobin values, higher platelet counts, and a lower thrombosis risk vs JAK2-mutated ET. Calreticulin-mutated ET appears to be a distinct entity with a more indolent course.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/blood-2014-01-547596 | DOI Listing |
Publication Analysis
Top Keywords
faces calr
4
calr jak2
4
jak2 issue
4
issue blood
4
blood rumi
4
rumi rotunno
4
rotunno demonstrate
4
demonstrate essential
4
essential thrombocythemia
4
thrombocythemia patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!